Healthequity (2HE) Ratios
Healthequity Ratios
DE:2HE's free cash flow for Q2 2027 was $135.18M. For the 2027 fiscal year, DE:2HE's free cash flow was decreased by $-978.00K and operating cash flow was $136.16M. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.27 | 3.06 | 4.76 | 2.92 | 2.29 |
| Quick Ratio | 3.27 | 3.06 | 4.76 | 2.92 | 2.29 |
| Cash Ratio | 2.03 | 1.89 | 3.45 | 1.94 | 1.47 |
| Solvency Ratio | 0.28 | 0.19 | 0.18 | 0.11 | 0.07 |
| Operating Cash Flow Ratio | 2.91 | 2.17 | 2.07 | 1.15 | 0.92 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 8.61 | 16.11 |
| Net Current Asset Value | $ -812.57M | $ -855.89M | $ -571.33M | $ -810.37M | $ -903.19M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.32 | 0.29 | 0.32 | 0.32 |
| Debt-to-Equity Ratio | 0.48 | 0.52 | 0.46 | 0.52 | 0.54 |
| Debt-to-Capital Ratio | 0.32 | 0.34 | 0.31 | 0.34 | 0.35 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.33 | 0.30 | 0.32 | 0.33 |
| Financial Leverage Ratio | 1.63 | 1.63 | 1.55 | 1.63 | 1.68 |
| Debt Service Coverage Ratio | 7.47 | 5.25 | 4.74 | 2.78 | 2.77 |
| Interest Coverage Ratio | 5.64 | 3.79 | 2.31 | 0.78 | 1.11 |
| Debt to Market Cap | 0.13 | 0.11 | 0.14 | 0.18 | 0.21 |
| Interest Debt Per Share | 12.29 | 13.46 | 11.55 | 12.35 | 12.57 |
| Net Debt to EBITDA | 1.40 | 2.41 | 1.87 | 4.32 | 7.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.52% | 57.73% | 53.01% | 45.90% | 45.06% |
| EBIT Margin | 25.47% | 14.59% | 12.94% | 1.20% | -4.52% |
| EBITDA Margin | 37.25% | 28.13% | 28.25% | 19.90% | 13.61% |
| Operating Profit Margin | 24.55% | 19.18% | 12.82% | 4.37% | 5.36% |
| Pretax Profit Margin | 21.12% | 9.67% | 7.51% | -4.42% | -8.82% |
| Net Profit Margin | 16.38% | 8.06% | 5.57% | -3.03% | -5.85% |
| Continuous Operations Profit Margin | 16.38% | 8.06% | 5.57% | -3.03% | -5.85% |
| Net Income Per EBT | 77.57% | 83.34% | 74.24% | 68.62% | 66.36% |
| EBT Per EBIT | 86.04% | 50.43% | 58.56% | -101.18% | -164.52% |
| Return on Assets (ROA) | 6.27% | 2.80% | 1.76% | -0.85% | -1.43% |
| Return on Equity (ROE) | 10.21% | 4.57% | 2.74% | -1.38% | -2.39% |
| Return on Capital Employed (ROCE) | 9.85% | 6.99% | 4.21% | 1.27% | 1.37% |
| Return on Invested Capital (ROIC) | 7.61% | 5.81% | 3.11% | 0.87% | 0.90% |
| Return on Tangible Assets | 31.34% | 16.23% | 8.20% | -5.18% | -9.07% |
| Earnings Yield | 2.92% | 1.01% | 0.86% | -0.51% | -1.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.62 | 10.17 | 9.53 | 8.90 | 8.65 |
| Payables Turnover | 32.92 | 35.32 | 39.01 | 33.55 | 15.09 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 33.26 | 25.84 | 18.38 | 12.43 | 8.70 |
| Asset Turnover | 0.38 | 0.35 | 0.32 | 0.28 | 0.24 |
| Working Capital Turnover Ratio | 3.88 | 3.15 | 2.89 | 3.83 | 3.34 |
| Cash Conversion Cycle | 23.29 | 25.57 | 28.95 | 30.13 | 17.99 |
| Days of Sales Outstanding | 34.37 | 35.90 | 38.30 | 41.02 | 42.18 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 11.09 | 10.33 | 9.36 | 10.88 | 24.19 |
| Operating Cycle | 34.37 | 35.90 | 38.30 | 41.02 | 42.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.31 | 3.91 | 2.84 | 1.78 | 1.70 |
| Free Cash Flow Per Share | 5.28 | 3.89 | 2.30 | 0.37 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 232.15 | 163.08 | 5.27 | 1.26 | 1.03 |
| Capital Expenditure Coverage Ratio | 232.15 | 163.08 | 5.27 | 1.26 | 1.03 |
| Operating Cash Flow Coverage Ratio | 0.46 | 0.31 | 0.26 | 0.15 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.35 | 0.28 | 0.24 | 0.17 | 0.19 |
| Free Cash Flow Yield | 6.17% | 3.52% | 3.04% | 0.61% | 0.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 34.27 | 99.48 | 116.08 | -196.55 | -100.31 |
| Price-to-Sales (P/S) Ratio | 5.62 | 7.99 | 6.47 | 5.96 | 5.87 |
| Price-to-Book (P/B) Ratio | 3.50 | 4.54 | 3.18 | 2.71 | 2.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.21 | 28.40 | 32.87 | 163.00 | 1135.06 |
| Price-to-Operating Cash Flow Ratio | 16.14 | 28.22 | 26.63 | 34.11 | 31.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.27 | 1.41 | -0.37 | 4.73 | 0.19 |
| Enterprise Value Multiple | 16.48 | 30.82 | 24.77 | 34.27 | 50.75 |
| Enterprise Value | 8.06B | 10.40B | 7.00B | 5.88B | 5.23B |
| EV to EBITDA | 16.48 | 30.82 | 24.77 | 34.27 | 50.75 |
| EV to Sales | 6.14 | 8.67 | 7.00 | 6.82 | 6.91 |
| EV to Free Cash Flow | 17.71 | 30.80 | 35.56 | 186.48 | 1335.06 |
| EV to Operating Cash Flow | 17.64 | 30.62 | 28.81 | 39.02 | 37.06 |
| Tangible Book Value Per Share | -7.41 | -8.49 | -5.25 | -8.16 | -9.22 |
| Shareholders’ Equity Per Share | 24.46 | 24.35 | 23.78 | 22.45 | 22.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.17 | 0.26 | 0.31 | 0.34 |
| Revenue Per Share | 15.25 | 13.81 | 11.68 | 10.21 | 9.10 |
| Net Income Per Share | 2.50 | 1.11 | 0.65 | -0.31 | -0.53 |
| Tax Burden | 0.78 | 0.83 | 0.74 | 0.69 | 0.66 |
| Interest Burden | 0.83 | 0.66 | 0.58 | -3.69 | 1.95 |
| Research & Development to Revenue | 0.20 | 0.20 | 0.22 | 0.22 | 0.21 |
| SG&A to Revenue | 0.25 | 0.19 | 0.10 | 0.11 | 0.11 |
| Stock-Based Compensation to Revenue | 0.06 | 0.08 | 0.08 | 0.07 | 0.07 |
| Income Quality | 2.12 | 3.51 | 4.36 | -5.76 | -3.18 |
Currency in USD